SANUWAVE Health, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-682.0K | $-1.4M | $7.7M | $9.7M | $551.0K | $-6.1M | $-13.3M | $-21.2M |
| Depreciation & Amortization | $251.0K | $294.0K | $369.0K | $222.0K | $174.0K | $209.0K | $266.0K | $206.0K |
| Depreciation | $137.0K | $118.0K | — | — | $72.0K | $69.0K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.5M | $1.6M | $1.3M | $1.4M | $1.1M | $975.0K | $1.5M | $0 |
| Net Cash from Operating Activities | $425.0K | $397.0K | $3.3M | $1.1M | $993.0K | $-1.5M | $741.0K | $1.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $334.0K | $23.0K | $96.0K | $525.0K | $1.2M | $162.0K | $236.0K | $48.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-448.0K | $-158.0K | $279.0K | $4.5M | $-1.2M | $-162.0K | $-236.0K | $-48.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-1.4M | $-1.4M | $-1.2M | $-4.5M | $161.0K | $-57.0K | $6.5M | $-435.0K |
| Net Change in Cash | $-1.4M | $-1.2M | $2.4M | $1.1M | $-5.0K | $-1.7M | $7.0M | $799.0K |
| Free Cash Flow | $91.0K | $374.0K | $3.2M | $556.0K | $-166.0K | $-1.7M | $505.0K | $1.2M |